Patents by Inventor Yu Shan Wei

Yu Shan Wei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240033307
    Abstract: A method for enhancing sports performance and alleviating sarcopenia with a Streptococcus thermophiles ST7 fermentation product composition is disclosed. The administration of an effective amount of the Streptococcus thermophiles ST7 fermentation product composition to an individual in advance can increase the ATP content of the individual's muscle cells and lower indices related to fatigue and muscle damage, thereby enhancing the individual's sports performance and improving or preventing sarcopenia and its symptoms.
    Type: Application
    Filed: November 29, 2022
    Publication date: February 1, 2024
    Inventors: Wei-Jen CHEN, Tsung-Yin TANG, Ming-Chung TSENG, Yu-Shan WEI
  • Patent number: 11510949
    Abstract: The present invention relates to the use of a novel Lactobacillus brevis ProGA28 strain, deposited in the German Collection for Microorganisms and Cell Cultures (DSMZ) under the accession number DSM 33167 on May 28, 2019. The metabolites of Lactobacillus brevis ProGA28 have the ability to improve sleep quality, can effectively reduce the time of rapid eye movement in the sleep phase, can reduce time to fall asleep, can increase total sleep time, and can increase the ratio of low waves during sleep so that sleep disorders and related complications, such as anxiety and immune system diseases, are treated.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: November 29, 2022
    Assignee: SYNGEN BIOTECH CO., LTD
    Inventors: Wei-Jen Chen, Bing-Huang Gau, Po-An Chen, Yu-Shan Wei
  • Publication number: 20210023148
    Abstract: The present invention discloses a novel Lactobacillus brevis ProGA28, deposited in the German Collection for Microorganisms and Cell Cultures, the accession number is DSM 33167, and the deposit date is on 28 May, 2019. The metabolites of the novel Lactobacillus brevis ProGA28 has the ability to improve sleep quality, and can effectively reduce the time of rapid eye movement in sleep phase, reduce the number of falling asleep, increase the total sleep time, prolong the time of single falling asleep, and increase the ratio of low waves during sleep, so that it can achieve the effect of treating or improving sleep disorders and related complications, such as anxiety and immune system diseases.
    Type: Application
    Filed: July 23, 2020
    Publication date: January 28, 2021
    Inventors: Wei-Jen CHEN, Bing-Huang GAU, Po-An CHEN, Yu-Shan WEI
  • Patent number: 10647174
    Abstract: An in-car temperature-controlling device for a car in its parked state uses a wireless remote control to remotely control a power-activating unit, an engine-starting unit, a window-activating unit and an AC-activating unit of the car, so as to adjust the car's in-car temperature. Its installation is easy and needs no structural changes to the car, so the car using the device can, in its parked state, have its in-car temperature prevented from being too high or too low. The in-car temperature-controlling device is characterized in contributing to convenience, safety, comfort and low costs, and is applicable to all existing and newly built cars.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: May 12, 2020
    Assignee: National Chin-Yi University of Technology
    Inventors: Kuo Yi Li, Yu Shan Wei, Jie Ru Lu, Bing Wei Wu, Yi Lung Chiu, Sy Cheng, Ching Jan Shiu
  • Publication number: 20170368905
    Abstract: An in-car temperature-controlling device for a car in its parked state uses a wireless remote control to remotely control a power-activating unit, an engine-starting unit, a window-activating unit and an AC-activating unit of the car, so as to adjust the car's in-car temperature. Its installation is easy and needs no structural changes to the car, so the car using the device can, in its parked state, have its in-car temperature prevented from being too high or too low. The in-car temperature-controlling device is characterized in contributing to convenience, safety, comfort and low costs, and is applicable to all existing and newly built cars.
    Type: Application
    Filed: September 11, 2017
    Publication date: December 28, 2017
    Inventors: KUO YI LI, YU SHAN WEI, JIE RU LU, BING WEI WU, YI LUNG CHIU, SY CHENG, CHING JAN SHIU
  • Publication number: 20170211131
    Abstract: The present invention provides a method for evaluating oral health, in particularly for evaluating a risk for suffering from periodontal disease, comprising: (1) providing an oral sample of a subject; (2) detecting at least two indicator microbes in the oral sample; and (3) analyzing amounts of the at least two indicator microbes; wherein when each of the amounts of the at least two indicator microbes is higher than a standard value for an amount of a corresponding indicator microbe, it indicates that the subject has a high risk for suffering from periodontal disease.
    Type: Application
    Filed: November 2, 2016
    Publication date: July 27, 2017
    Applicant: GENERAL BIOLOGICALS CORPORATION
    Inventors: Wen-Chi Cheng, YI-RU CHANG, YU-SHAN WEI, Ming-Sun Liu, HONG-LIN CHAN, Frank Lin
  • Publication number: 20160263962
    Abstract: An in-car temperature-controlling device for a car in its parked state uses a wireless remote control to remotely control a power-activating unit, an engine-starting unit, a window-activating unit and an AC-activating unit of the car, so as to adjust the car's in-car temperature. Its installation is easy and needs no structural changes to the car, so the car using the device can, in its parked state, have its in-car temperature prevented from being too high or too low. The in-car temperature-controlling device is characterized in contributing to convenience, safety, comfort and low costs, and is applicable to all existing and newly built cars.
    Type: Application
    Filed: March 10, 2016
    Publication date: September 15, 2016
    Inventors: KUO YI LI, YU SHAN WEI, JIE RU LU, BING WEI WU, YI LUNG CHIU, SY CHENG, CHING JAN SHIU
  • Patent number: 8349316
    Abstract: The present invention provides a strain of Lactobacillus fermentum SG-A95 with deposit number of CGMCC NO. 3248 and a fermentation product thereof. The present invention also provides a health care composition for improving oral bacteria population, which comprises the Lactobacillus fermentum SG-A95 or the fermentation product thereof.
    Type: Grant
    Filed: October 8, 2010
    Date of Patent: January 8, 2013
    Assignee: Syngen Biotech, Co., Ltd.
    Inventors: Chu Yang Hsieh, Yu Shan Wei, Chi Chiang Yang
  • Publication number: 20110262372
    Abstract: The present invention provides a strain of Lactobacillus fermentum SG-A95 with deposit number of CGMCC NO. 3248 and a fermentation product thereof. The present invention also provides a health care composition for improving oral bacteria population, which comprises the Lactobacillus fermentum SG-A95 or the fermentation product thereof.
    Type: Application
    Filed: October 8, 2010
    Publication date: October 27, 2011
    Applicant: SYNGEN BIOTECH CO., LTD.
    Inventors: Chu Yang Hsieh, Yu Shan Wei, Chi Chiang Yang
  • Publication number: 20100322960
    Abstract: A Ganoderma tsugae active substance, produced from Ganoderma tsugae by following steps: (1) liquid culturing Ganoderma tsugae; (2) extracting the fermentation filtrate obtained with ethanol to obtain ethanol extraction precipitate; (3) purifying the ethanol extraction precipitate obtained by gel filtration chromatography to obtain gel filtration chromatographed product; and (4) extracting the gel filtration chromatographed product obtained with acetone to obtain the supernatant as the desired Ganoderma tsugae active substance.
    Type: Application
    Filed: June 22, 2009
    Publication date: December 23, 2010
    Applicant: Syngen Biotech Co., Ltd.
    Inventors: Yu-Shan Wei, Chia-Wen Hsieh, Being-Sun Wung
  • Publication number: 20100196341
    Abstract: A novel Lactobacillus paracasei subsp. paracasei SG96, a bacteriostatic composition containing the same and use thereof, comprise a novel Lactobacillus paracasei subsp. paracasei SG96 strain, wherein said strain had been deposited in China General Microbiological Culture Collection Center, CGMCC, accession number: CGMCC 2697, characterized in that said strain can inhibit the growth of pathogenic bacteria such as Escherichia coli, Salmonella typhimurium and the like, and even has an effect of killing bacteria; and a bacteriostatic composition containing said Lactobacillus paracasei subsp. paracasei SG96 strain, characterized in that said composition can be used as an additive in animal drinking water, as an additive in animal feed, as an medical composition for animals and humans, as an additive in food products as an additive in beverages, and as a food product, beverage, and health food products, and the like.
    Type: Application
    Filed: February 5, 2009
    Publication date: August 5, 2010
    Applicant: SYNGEN BIOTECH CO., LTD.
    Inventors: Yu-Shan WEI, Fang-Yun TAI